Crohn's is a chronic recurrent inflammatory disorder of the gastrointestinal tract that produces frequent diarrhea, abdominal pain, and weight loss due to malabsorption of nutrients in more severe cases. With a Crohn's mouse model, a novel study published in the journal Cell described the interplay between a risk allele found in humans and a pathogen derived from the environment. The study offers general insight into why certain risk alleles may have low penetrance in human disease.
The authors studied the Crohn's susceptibility allele Atg16L1 in mice, which the investigators point out, is present in nearly 50% of Europeans and confers less than a 2 fold increase in Crohn's risk . Interestingly, the authors observed that when mice were isolated from their littermates, the mutation of Atg16L1 confers a phenotype very similar to wild type mice. However, when raised with other mice, Atg16L1 mutation mimics a phenotype observed in the gastrointestinal tract similar to Crohn's disease. Specifically an abnormality in paneth cells, a cell type that releases enzymes involved in host defense in the intestines.
The investigators found that taking isolated mice with the mutation, which have paneth cells similar to wild type, and infecting them with a gastrointestinal specific virus was sufficient to trigger the Crohn's like paneth cell phenotype. Suggesting, that the environment and inflammation may play an significant role in the penetrance of Crohn's risk alleles. The authors observed that inoculating mutant mice with virus followed by treatment with dextran sodium sulfate (DSS), a gastrointestinal irritating agent, led to inflammation very similar to what is present in Crohn's disease. Like Crohn's disease, this inflammation and damage could be ameliorated with anti-TNF and antibiotics in the mice.
This study suggests that although disease risk alleles may have low penetrance within a population, their ability to induce disease may be regulated by outside factors. The example described in this study was a viral infection interacting with a gene that regulates host defense. Without the virus, the mutation did not confer a Crohn's phenotype. The observations made by the investigators of this study further underscores the importance of the interplay between environment and genetics in understanding disease.
References:
Cadwell, K. et, al. Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine. Cell 141, 1135-1145, June 25, 2010
Published by S.T. Charette
S.T. Charette has been trained as a research scientist in the fields of genetics and immunology. Specifically, in the areas of cancer and diabetes. He is currently earning a Pharm.D. at ACPHS. View profile
- Crohn's Gene Identified in ChildrenCrohn's Disease is a very painful disorder related to the inflammation of the gastrointestinal tract. Pediatricians have recently ..
- Crohn's Disease - Symptoms and TreatmentsCrohn's disease presents with vague symptoms, often taking years to receive a diagnosis and treatment plan.
My Brother's Diagnosis with Crohn's and Information About This DiseaseMy brother was diagnosed with Crohn's Disease the middle of November and spent several days in the hospital on IV antibiotic therapy and anti-inflammation medications. - Best Crohn's Websites and Online Resources If you search for "Crohn's" or "Crohn's Resources" with your favorite search engine, you'll get pages and pages of websites and webpages. A few of them are actually worth your time.
- Osteoporosis FactsOsteoporosis is often called the silent disease. Most people do not know they have osteoporosis until they fracture a bone. Hips, spines, wrists, and ribs are the most common osteoporosis related fracture sites.
- Pediatric Crohn's Disease; Remicade as a New Treatment Option
- CROHN'S DISEASE FACTS REVEALED
- What is Crohn's Disease?
- Crohn Disease and Omega-3 Free Fatty Acids: Do These Supplements Make a Difference?
- New Genetic Risk Factors Identified in Crohn's Disease
- Your Health: Celiac Disease
- Prevention of Multiple Operations in Crohn's Disease Patients Using Immunosuppress...



